Skip to main content
GutCited
Figure 1

More Figures from This Paper

Figure 3

Figure 3

Figure 1

735 × 463px · 228.4 KB

Source Paper

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease.

Pharmaceuticals (Basel, Switzerland) (2025)

PMID: 40006091

DOI: 10.3390/ph18020279

Cite This Figure

![Figure 1: Figure 1](https://pdfs.citedhealth.com/figures/40006091/190.png)

> Source: Daniela Ciobârcă et al. "Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (." *Pharmaceuticals (Basel, Switzerland)*, 2025. PMID: [40006091](https://pubmed.ncbi.nlm.nih.gov/40006091/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/40006091/190.png" alt="Figure 1" />
  <figcaption>Figure 1. Figure 1<br>  Source: Daniela Ciobârcă et al. "Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40006091/">40006091</a></figcaption>
</figure>

Related Evidence

D
Berberine for Gut Dysbiosis

Grade D · 2 studies